Rituxan (rituximab) - Roche
Vyvgart (efgartigimod alfa-fcab) - argenx, Broteio
Case Report: A case of anti-mGluR1 antibody-associated encephalitis treated with efgartigimod combined with rituximab. (PubMed, Front Immunol) - Sep 19, 2026 - "At the 12-month follow-up, the patient's clinical symptoms continued to improve, with no observed relapse. This case report underscores the importance of early diagnosis and therapeutic intervention, highlighting the need to suspect this condition based on its characteristic clinical presentation." 
Journal • Ataxia • CNS Disorders • Epilepsy • Immunology • Movement Disorders • Psychiatry
http://www.ncbi.nlm.nih.gov/pubmed/42756386
 
Chao Zhao; Juntong Liu; Lan Gao; Wenping Zhu
 
Sep 19, 2026
 
Prev Next